CT-1042, a novel anticancer agent, exhibits effects by activating p53 and inhibiting survivinONCOLOGY REPORTSIF3.92018-04-044OAAI
Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on Si 80-Bearing/Residual MouseJOURNAL OF FOOD SCIENCEIF3.42016-11-0128PREAI
Preparation, Characterization, and Pharmacodynamics of Thermosensitive Liposomes Containing DocetaxelJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82014-07-0144PREAI
Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine SiteJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-02-0663OAAI
Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherinEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72008-06-0144PREAI